Lloyd Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Lloyd Advisory Services's AZN Position: Q2 2026 in Review
Lloyd Advisory Services increased its AstraZeneca (AZN) stake by 54% in Q2 2026, buying an estimated $6.96K and bringing the position to 105 shares worth $19.8K. The position accounts for 0.01% of the portfolio, ranked #320.
Lloyd Advisory Services first reported a position in AZN in Q4 2019 and has held it in 4 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Lloyd Advisory Services held 105 shares of AstraZeneca worth $19.8K as of Q2 2026.
- Lloyd Advisory Services bought 37 AstraZeneca shares in Q2 2026, an estimated $6.96K.
- AstraZeneca made up 0.01% of Lloyd Advisory Services's portfolio in Q2 2026, its #320 holding.
- Lloyd Advisory Services first reported a position in AstraZeneca in Q4 2019 and has held it in 4 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.